{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:27:32Z","timestamp":1778833652265,"version":"3.51.4"},"reference-count":23,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":692,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,2]]},"abstract":"<jats:p>Seventy\u2010eight patients with haematological malignancies, received T\u2010cell\u2010depleted stem cell transplants and cyclosporin followed by delayed add\u2010back of donor lymphocytes to prevent leukaemia relapse. The source of stem cells was bone marrow in 50 patients and granulocyte colony\u2010stimulating factor (G\u2010CSF)\u2010mobilized peripheral blood in 28 patients. In univariate analysis, only the CD34+ cell dose (but not the stem cell source or the T lymphocyte dose) and disease status were predictive for transplant\u2010related mortality, relapse and survival. Patients receiving \u2265\u20033\u2003\u00d7\u200310<jats:sup>6<\/jats:sup> CD34+ cells\/kg had an overall actuarial survival of 68% compared with 52%, 35% and 10%, respectively, for cell doses of 2\u20132.99, 1\u20131.99 and &lt;\u20031\u2003\u00d7\u200310<jats:sup>6<\/jats:sup>\/kg. Multivariate analysis of risk factors for relapse identified disease risk and CD34+ cell dose as the only factors. Relapse was 62.5% in 38 patients at high risk of relapse vs. 25% for 40 patients at intermediate or low risk. CD34+ cell doses of \u2265\u20033\u2003\u00d7\u200310<jats:sup>6<\/jats:sup>\/kg were associated with a 13.5% relapse vs. 48% for recipients of lower doses. This favourable effect of CD34+ cell dose on relapse was apparent in both high\u2010 and intermediate\u2010 plus low\u2010risk groups. Our results support the potential benefit of a high stem cell dose in lowering transplant\u2010related mortality (TRM) and in reducing relapse after allogeneic marrow or blood stem cell transplants.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.01838.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:21:45Z","timestamp":1047363705000},"page":"408-414","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["CD34+ cell dose predicts relapse and survival after T\u2010cell\u2010depleted HLA\u2010identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies"],"prefix":"10.1111","volume":"108","author":[{"family":"Bah\u00e7eci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Read","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Leitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Childs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"53","article-title":"Bone marrow transplantation for chronic myeloid leukemia: T cell depletion with Campath\u20101 reduces the incidence of acute graft\u2010versus\u2010host disease but may increase the risk of leukemic relapse","volume":"1","author":"Apperley J.F.","year":"1986","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T\u2010cell\u2010depleted haploidentical \u2018three\u2010loci\u2019 incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony\u2010stimulating factor\u2010mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa F.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_4_2","first-page":"409","article-title":"Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single\u2010center experience","volume":"26","author":"Bacigalupo A.","year":"1998","journal-title":"Experimental Hematology"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701131"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb06744.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.10.2547"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.7.2794.bloodjournal8872794"},{"key":"e_1_2_6_9_2","first-page":"185","article-title":"T\u2010cell depletion in bone marrow transplantation for leukemia: current results and future directions","volume":"3","author":"Butturini A.","year":"1988","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_10_2","first-page":"320","article-title":"Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell\u2010depletion equivalent to elutriation","volume":"23","author":"Cottler\u2010Fox M.","year":"1995","journal-title":"Experimental Hematology"},{"key":"e_1_2_6_11_2","first-page":"347","article-title":"Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T\u2010depleted BMT for adults with hematological malignancies","volume":"18","author":"Couriel D.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_12_2","first-page":"S16","article-title":"Superior antileukemic activity of murine peripheral blood progenitor cell (PBPC) grafts mobilized by G\u2010CSF and stem cell factor (SCF) as compared to G\u2010CSF alone","volume":"21","author":"Hartung G.","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_13_2","first-page":"329","article-title":"Delayed infusion of normal donor cells after MHC\u2010matched bone marrow transplantation provides an antileukemia reaction without graft\u2010versus\u2010host disease","volume":"11","author":"Johnson B.D.","year":"1993","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.8.2120.2120"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood.V88.8.3223.bloodjournal8883223","article-title":"CD34+ cell dose predicts survival, posttransplant morbidity and rate of hematological recovery after allogeneic marrow transplants for hematologic malignancies","volume":"88","author":"Mavroudis D.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/scd.1.1998.7.151","article-title":"CD34 augmentation improves allogeneic T cell\u2010depleted bone marrow engraftment","volume":"7","author":"Noga S.J.","year":"1998","journal-title":"Journal of Hematotherapy"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.2307\/2344317"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91835-X"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(95)80021-2"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198507000-00009"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990160111"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.11.4226"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.10.3961.bloodjournal86103961"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01838.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01838.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.01838.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T08:21:19Z","timestamp":1698567679000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.01838.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["10.1046\/j.1365-2141.2000.01838.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.01838.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}